Accessibility Menu
Covalon Technologies logo

Covalon Technologies

(OTC) CVALF

Current Price$1.54
Market Cap$42.53M
Since IPO (2012)+173%
5 Year+37%
1 Year-4%
1 Month+9%

Covalon Technologies Financials at a Glance

Market Cap

$42.53M

Revenue (TTM)

CA$32.70M

Net Income (TTM)

CA$1.64M

EPS (TTM)

$0.04

P/E Ratio

35.57

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$1.54

Volume

65,311

Open

$1.58

Previous Close

$1.54

Daily Range

$1.54 - $1.59

52-Week Range

$1.16 - $2.00

Estimated Earnings Date

Aug 20, 2026

CVALF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Covalon Technologies

Industry

Biotechnology

CEO

Brent Ashton

Headquarters

Mississauga, ON L4W 5S7, CA

CVALF Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

3%

Net Income Margin

5%

Return on Equity

6%

Return on Capital

4%

Return on Assets

5%

Earnings Yield

2.81%

Dividend Yield

0.00%

Payout Ratio

2.52%

Stock Overview

Market Cap

$42.53M

Shares Outstanding

27.62M

Volume

65.31K

Avg. Volume

6.97K

Financials (TTM)

Gross Profit

CA$17.47M

Operating Income

CA$1.76M

EBITDA

CA$2.72M

Operating Cash Flow

CA$1.64M

Capital Expenditure

-CA$462.52K

Free Cash Flow

CA$1.18M

Cash & ST Invst.

CA$17.37M

Total Debt

CA$2.25M

Covalon Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$8.75M

+15.3%

Gross Profit

CA$5.17M

+25.0%

Gross Margin

59.14%

N/A

Market Cap

$42.53M

N/A

Market Cap/Employee

$405.07K

N/A

Employees

105

N/A

Net Income

CA$1.10M

+155.5%

EBITDA

CA$1.17M

+126.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$16.61M

-7.9%

Total Debt

CA$1.78M

+191.8%

Accounts Receivable

CA$4.71M

-6.2%

Inventory

CA$6.39M

-28.4%

Long Term Debt

CA$1.45M

+1209.7%

Short Term Debt

CA$664.91K

+33.2%

Return on Assets

4.95%

N/A

Return on Invested Capital

3.87%

N/A

Free Cash Flow

-CA$1.33M

-306.6%

Operating Cash Flow

-CA$1.15M

-271.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNMFAmplia Therapeutics Limited
$0.08+0.00%
SEOVFSernova Corp.
$0.11-12.00%
ACHFFArch Biopartners Inc.
$0.48+37.51%
OTLCOncotelic Therapeutics, Inc.
$0.05+7.67%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.99+0.04%
NFLXNetflix
$77.38+0.01%
CMCSAComcast
$22.38-0.01%
BACBank of America
$56.20-0.01%

Questions About CVALF

What is the current price of Covalon Technologies?

Covalon Technologies is trading at $1.54 per share.

What is the 52-week range for Covalon Technologies?

Over the past 52 weeks, Covalon Technologies has traded between $1.16 and $2.00.

How much debt does Covalon Technologies have?

As of the most recent reporting period, Covalon Technologies reported total debt of CA$1.27M.

How much cash does Covalon Technologies have on hand?

Covalon Technologies reported CA$11.87M in cash and cash equivalents in its most recent financial results.

What is Covalon Technologies’s dividend yield?

Covalon Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.